Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Instil Bio, Inc. Director's Dealing 2024

Jan 11, 2024

33728_dirs_2024-01-10_1cf67a49-0ba7-4b3e-86f2-7d12307ec5e8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Instil Bio, Inc. (TIL)
CIK: 0001789769
Period of Report: 2023-06-14

Reporting Person: Nielsen Jack (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-06-14 Stock Option (Right to Buy) $11.18 A 1500 Acquired 2033-06-13 Common Stock (1500) Direct

Footnotes

F1: The option will vest in 12 equal monthly installments commencing on July 14, 2023, subject to the Report Person's continued service as a director through the vesting date.